Search News
| 27.21 Delayed Data As of Aug 15 |  +1.51 / +5.88%Today’s Change | 21.52 Today|||52-Week Range 74.39 | -40.98% Year-to-Date |
The investment seeks daily investment results- before fees and expenses- of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund- under normal circumstances- invests in swap agreements- futures contracts- short positions or other financial instruments that- in combination- provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
| 1 month | +24.45% | 3 years | -58.76% | |
| 3 months | -6.77% | 5 years | -- | |
| 1 year | -60.24% | Since inception | -56.65% |
| Previous close | $25.70 |
| Open day’s range | 25.96 – 27.62 |
| Net asset value (NAV) | 27.28 (08/15/2018) |
| Daily volume | 1,454,077 |
| Average volume (3 months) | 1,343,264 |
| LABD | Category | |
|---|---|---|
| Performance 5-yr return | -- | -29.79% |
| Expense Gross exp ratio | 1.14% | 1.94% |
| Risk 5 year sharpe ratio | -- | -- |
| Net assets | $60.9M | $3.4M |
| Average market cap | -- | -- |
| Average P/E | -- | -- |
| Dividend / Share | -- | 0.35% |
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
| Holdings not available. |
